Key points are not available for this paper at this time.
To the Editor: It is considered potentially harmful to administer imipenem–cilastatin to patients with IgE-mediated hypersensitivity to penicillins1 because of a 47.4 percent rate of cross-reactivi...
Romano et al. (Wed,) studied this question.